Details

---

Manufacturer
Mylan Laboratories Limited(INDIA)
Registraction Number
MAL24066028AZ

Here’s a summary of Acriptega Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate Film-Coated Tablets (50 mg/300 mg/300 mg):

Contents

Active Ingredients:
Dolutegravir (50 mg).
Lamivudine (300 mg).
Tenofovir Disoproxil Fumarate (300 mg, equivalent to 245 mg of Tenofovir Disoproxil).

Indications

Used for the treatment of HIV-1 infection in adults and adolescents weighing at least 30 kg.
Indicated for post-exposure prophylaxis (PEP) to reduce the risk of HIV-1 infection following potential exposure.

Instructions

Dosage: One tablet daily, taken at the same time each day.
Administration:
Can be taken with or without food
Swallow the tablet whole with water; do not chew or crush.
Precautions:
Regular monitoring of kidney function and bone density is recommended.
Not suitable for individuals with severe kidney impairment.
Consult a healthcare provider if pregnant, breastfeeding, or taking othermedications.
Storage: Keep below 30°C, away from light and moisture.